Eden Research plc (LON:EDEN – Get Free Report) insider Alexander John Abrey acquired 540,540 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,852.46).
Eden Research Trading Down 2.7 %
LON:EDEN opened at GBX 3.94 ($0.05) on Friday. Eden Research plc has a 12-month low of GBX 3.30 ($0.04) and a 12-month high of GBX 6.20 ($0.08). The firm has a market cap of £21.01 million, a PE ratio of -200.00 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.25. The stock has a fifty day moving average price of GBX 3.89 and a 200 day moving average price of GBX 4.
About Eden Research
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Further Reading
- Five stocks we like better than Eden Research
- What Investors Need to Know About Upcoming IPOs
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Calculate Inflation Rate
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.